Poster (Scientific congresses and symposiums)
Real-World Effectiveness And Safety Of Upadacitinib For The Treatment Of Moderate To Severe Crohn’s Disease In A Belgian Multi-Centric Refractory Cohort
Pavlidi, Anastasia; Verstockt, Bram; Lobaton Ortega, Triana et al.
2024UEG Week Vienna 2024
Peer reviewed
 

Files


Full Text
MP328.pdf
Author postprint (635.21 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Disciplines :
Gastroenterology & hepatology
Author, co-author :
Pavlidi, Anastasia
Verstockt, Bram
Lobaton Ortega, Triana
Vieujean, Sophie  ;  Université de Liège - ULiège > Département des sciences cliniques > Hépato-gastroentérologie ; Centre Hospitalier Universitaire de Liège - CHU > > Service de gastroentérologie, hépatologie, onco. digestive
Baert, Filip
Dewit, Olivier
Rahier, Jean François
Ouziel, Romy
Hoyois, Alice
Holvoet, Tom
Couturier, Filip
Willandt, Barbara
Bossuyt, Peter
Somers, Michaël
Salame, Mikhaël
Verreth, Annelies
Franchimont, Denis
Cremer, Anneline
More authors (8 more) Less
Language :
English
Title :
Real-World Effectiveness And Safety Of Upadacitinib For The Treatment Of Moderate To Severe Crohn’s Disease In A Belgian Multi-Centric Refractory Cohort
Publication date :
12 October 2024
Event name :
UEG Week Vienna 2024
Event place :
Vienna, Austria
Event date :
October 12-15, 2024
By request :
Yes
Audience :
International
Peer reviewed :
Peer reviewed
Available on ORBi :
since 24 December 2024

Statistics


Number of views
15 (1 by ULiège)
Number of downloads
0 (0 by ULiège)

Bibliography


Similar publications



Contact ORBi